Australian Entertainment Stock News

The catalyst here is clear. Neuren Pharmaceuticals (ASX:NEU) just secured FDA approval for DAYBUE STIX, a new powder version of its Rett syndrome therapy that could broaden usage and deepen royalty streams. See our latest analysis for Neuren Pharmaceuticals. The market seems to be recognising that story, with the share price at A$19.28 after a strong year to date share price return of about 57 percent and a standout five year total shareholder return above 1,400 percent. This suggests...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

The Australian market is experiencing a period of uncertainty, with shares opening flat and lacking the anticipated end-of-year rally. Despite this cautious atmosphere, there are still opportunities for investors to explore, particularly in the realm of penny stocks. Although the term "penny stocks" may seem outdated, these smaller or newer companies can offer intriguing prospects for those willing to look beyond larger firms.

DroneShield (ASX:DRO) just landed a €2.8 million contract with Belgium for handheld drone jammers, a deal that neatly captures how fast European demand for counter drone tech is moving from trials to real deployment. See our latest analysis for DroneShield. The contract lands as DroneShield’s A$2.3 share price rides powerful momentum, with a 1 day share price return of 10.6 percent and year to date share price return above 200 percent. Its 1 year total shareholder return of roughly 274...

It's not a stretch to say that Income Asset Management Group Limited's ( ASX:IAM ) price-to-sales (or "P/S") ratio of...

With the business potentially at an important milestone, we thought we'd take a closer look at VBX Limited's ( ASX:VBX...

In early December 2025, Koninklijke Philips held a special call announcing a significant expansion of its distribution agreement for 4DMedical’s FDA-cleared, non-contrast CT:VQ ventilation and perfusion imaging solution. This move could materially widen commercial access to CT:VQ by leveraging Philips’ global imaging footprint, potentially accelerating hospital adoption of 4DMedical’s technology. We’ll now examine how the expanded Philips distribution for CT:VQ may influence 4DMedical’s...

It's not a stretch to say that Infotrust Ltd's ( ASX:ITS ) price-to-sales (or "P/S") ratio of 0.9x right now seems...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Although Fortifai Limited ( ASX:FTI ) shareholders have enjoyed a great week with the stock up 39%, insiders who sold...

Insiders who purchased AU$559.4k worth of Terragen Holdings Limited ( ASX:TGH ) shares over the past year recouped some...

It's not a stretch to say that Enero Group Limited's ( ASX:EGG ) price-to-sales (or "P/S") ratio of 0.3x right now...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

AGL Energy (ASX:AGL) has joined Origin in courting private capital for its green energy and utility assets, marking a strategic shift that could reshape how investors think about funding Australia’s energy transition. See our latest analysis for AGL Energy. The latest push to bring private capital into AGL’s renewables and grid assets comes after a choppy year, with a negative year to date share price return but a solid three year total shareholder return. This signals that longer term...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Most readers would already know that Endeavour Group's (ASX:EDV) stock increased by 2.2% over the past month. Given...

Insiders who bought HITIQ Limited ( ASX:HIQ ) stock lover the last 12 months are probably not as affected by last...

Key Insights Significant control over Catapult Sports by retail investors implies that the general public has more...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Gold Hydrogen Limited's (ASX:GHY) stock price has dropped 10% in the previous week, but insiders who sold AU$4.8m in...

Zip Co (ASX:ZIP) has been busy reshaping its share base, buying back millions of ordinary shares while simultaneously issuing new securities and performance rights. For investors, these moves quietly reshape dilution, earnings per share and future upside. See our latest analysis for Zip Co. These capital moves come after a choppy run, with the share price now at A$3.03 and a modest year to date share price return of 2.02 percent. However, the three year total shareholder return of 388.71...

The Australian stock market recently experienced a mixed performance, with materials dragging the indices down while discretionary stocks showed some resilience. In this fluctuating environment, dividend stocks can offer a stable income stream, making them an appealing choice for investors seeking consistent returns amidst market volatility.

As the Australian market navigates a mixed landscape with tech stocks showing resilience amidst broader sector fluctuations, investors are keenly observing how economic indicators and global events influence small-cap performance. In this environment, identifying high growth tech stocks involves looking for companies that demonstrate robust innovation and adaptability to changing market dynamics.